Defense World
02 Jan 2026, 08:38 UTC · 41w ago
Impact · against what's priced in
The reduction in short interest for SCNI is a negligible event. The absolute number of shares shorted (24,933) is insignificant relative to the average daily volume of 61,206 shares, providing no meaningful catalyst for price movement.
No priced-in read yet
What the story claims
2 claims · scored −1 bearish … +1 bullish
Short interest in Scinai Immunotherapeutics (SCNI) decreased by 15.6% between November 30 and December 15.
More positive than 57% of claims this week
The total short interest for SCNI as of December 15th stood at 24,933 shares.
Continue reading
5 related stories
While short interest decreased by 15.6% to 24,933 shares, the total volume of short positions remains too small relative to the 61,206 average daily volume to meaningfully impact the stock price.
Read from the article alone
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Near neutral — 99% of claims this week are stronger
Which stocks this story touches
More positive than 58% of ticker scores this week
A decrease in short interest is generally viewed as a bullish signal as it suggests fewer investors are betting on the stock price to fall.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
2h ago
−90.3%
$0.6892 vs $7.12 close before publication (Dec 31) · not market-adjusted
SCNI chart →
